Centaur Clinical Cro

Centaur Clinical CRO review of the Méd’inov Connection Event in Lyon (April 3-4, 2024)

Medi’Nov is the annual must-attend trade fair dedicated to Medtech organized by First Connection. Organized since 2013, Medi’Nov Connection is a B2B Exhibition & Congress dedicated to medical technologies and innovation!

The event took place on April 3rd and 4th, 2024, and brought together industry leaders, researchers, innovators, and decision-makers to explore the latest advancements and emerging trends in the medical sector. This event was a significant gathering where innovation and collaboration were at the forefront of discussions in the healthcare field.

Centaur Clinical CRO exhibited during these exciting days. We had the opportunity to attend a series of stimulating conferences and inspiring presentations.

Centaur Clinical was able to share its ideas, establish strategic partnerships, and strengthen ties within the medical community. Similarly, we were able to explore an exhibition space showcasing the latest innovations in medical devices, biotechnology, and digital health solutions.

The Medinov event in Lyon once again demonstrated the importance of innovation and collaboration in addressing the complex challenges of healthcare.

Centaur Clinical CRO offers end-to-end support for CE marking of medical devices and its renewal.

Centaur Clinical stands out for its strategic and tailored approach to each project. In close collaboration with our clients, we identify specific needs and provide customized solutions that meet scientific and commercial objectives.

Centaur Clinical CRO is constantly striving to innovate and adopt new technologies and methodologies to improve the efficiency and quality of its services. Feel free to contact our team of preclinical experts for biocompatibility testing, clinical trials for your medical devices, Quality Management System (QMS), and regulatory affairs.

Centaur Clinical CRO supports you in demonstrating the biological safety of your device by identifying your needs with the help of its biologists and toxicologists, as well as by conducting biocompatibility tests in accordance with ISO 10993 and Good Laboratory Practice (GLP) standards.


We have an expert team in clinical operations and regulatory affairs who can assist the manufacturer of MD/IVD from clinical trial design to the preparation and drafting of regulatory dossiers and their submission to notified bodies.

The team’s multilingual skills and international connections enable us to conduct optimized studies worldwide.

Furthermore, our knowledge of applicable regulations with the FDA and other countries allows us to integrate relevant criteria for future extensions into desired countries from the outset.

Centaur Clinical CRO has a panel of experts for supporting and/or taking charge of the technical file of the device according to European regulations (MDR 2017/745-746) and the company’s Quality Management System (QMS) according to ISO 13485.

Don’t wait to realize your projects! Trust us to guide you towards success! 😊